Provider review
Noom Med tirzepatide review
Noom Med tirzepatide: dated cost records, plan details and questions to ask before enrolling. Public-source editorial, without a test purchase or clinical rating.
Updated 2026-09-18 · Public-source editorial · See dated evidence below
Noom built its reputation on behaviour change, and its medical arm is best understood as coaching with a prescription attached rather than the other way round.
Noom Med starts at $149 a month. There is also a lower-dose "microdose" programme from $79 a month with medication included, which is a genuinely different proposition and should not be compared on price against full-dose therapy.
Recorded costs and what to confirm
| Comparison step | Tirzepatide at Noom Med |
|---|---|
| Earlier figures | Dated cost record |
| Treatment | Name the product, route, prescribed amount and supply period |
| First payment | Itemize medicine, care, tests, supplies and delivery |
| Renewal | Give the next charge, its date and the supply it covers |
| Change or exit | Explain remaining charges and any refund before payment |
Availability by dose varies; the microdose programme is not full-dose therapy.
At $149 a month for the standard programme, Noom is priced like its competitors without the cost advantage of a flat-rate compounded seller. What you are buying for the difference is the behaviour-change apparatus, which for some people is exactly what was missing.
How Noom Med works
Behaviour-change app with a clinical arm. Sells a conventional GLP-1 programme and a lower-dose "microdose" programme with medication included.
The coaching is the product and it is well built — this is the one programme here where the non-medical support is the main event. Biomarker monitoring is folded in. Cancellation is straightforward, which is not universal in this market.
The earlier source record
- Noom Med listed from $149/month.
- Microdose GLP-1Rx programme listed from $79/month with medication included.
- Programme pairs low-dose medication with biomarker monitoring and coaching.
The underlying record is dated 2026-09-18. Its amounts, plan details and service descriptions are historical. Confirm the exact product, billing interval, included services and renewal terms before using a figure as a budget.
Where it is strong
- The coaching is the actual product here and it is well built.
- Medication is included in the microdose tier rather than billed separately.
- Straightforward cancellation.
Where it falls short
- Microdosing is not equivalent to the doses used in the trials people have read about.
- Full-dose therapy costs the same as competitors without the price advantage.
The thing most people miss
A $79 microdose programme is not the same treatment as 10 mg tirzepatide. Check the dose before comparing on price.
How it scored
The historical rubric gives Noom Med 3.5 out of 5. Display position 15 of 23 also reflects commercial placements; it is not a clinical quality rank. These scores have not been independently revalidated. See how we rate.
| What we weigh | Weight | Score |
|---|---|---|
| True monthly cost | 30% | 3.6 / 5 |
| Price honesty | 20% | 3.2 / 5 |
| Clinical support | 20% | 3.8 / 5 |
| Pharmacy sourcing | 15% | 3.3 / 5 |
| Cancelling | 15% | 3.6 / 5 |
Who it suits
Right for someone who has decided the medication alone has not worked and wants structured coaching alongside it. Wrong for someone who wants a full therapeutic dose at the lowest price.
Our verdict
The best coaching in this comparison, attached to unremarkable medication economics. Buy it for the programme, not the price. And be clear whether you are being offered a full dose or a microdose — they are not the same treatment.
How it compares on tirzepatide
| # | Provider | Cost record | Compare a new quote | Historical score |
|---|---|---|---|---|
| 1 | Coreage Rx Featured | Dated cost record | Product, supply, fees and renewal | 4.5 |
| 2 | SuperHealthy Rx | Dated cost record | Product, supply, fees and renewal | Not scored |
| 3 | Likeness Rx | Dated cost record | Product, supply, fees and renewal | Not scored |
| 4 | Trimi | Dated cost record | Product, supply, fees and renewal | 4.6 |
| 5 | PlexusDx | Dated cost record | Product, supply, fees and renewal | 4.4 |
| 6 | Ozari Health | Dated cost record | Product, supply, fees and renewal | 4.4 |
| 7 | Fifty 410 | Dated cost record | Product, supply, fees and renewal | 4.2 |
| 8 | Ivím Health | Dated cost record | Product, supply, fees and renewal | 4 |
| 9 | Mochi Health | Dated cost record | Product, supply, fees and renewal | 3.6 |
| 10 | Coby Health | Dated cost record | Product, supply, fees and renewal | 3.6 |
| 11 | Hims & Hers | Dated cost record | Product, supply, fees and renewal | 3.5 |
| 12 | Ro | Dated cost record | Product, supply, fees and renewal | 3.5 |
The full reasoning behind this order is in our best tirzepatide providers guide.
Read next
- Coreage Rx tirzepatide review
Coreage Rx tirzepatide: dated cost records, plan details and questions to ask before enrolling. Public-source editorial, without a test purchase or clinical rating.
- Likeness Rx semaglutide review
Likeness Rx semaglutide: dated cost records, plan details and questions to ask before enrolling. Public-source editorial, without a test purchase or clinical rating.
- Trimi tirzepatide review
Trimi tirzepatide: dated cost records, plan details and questions to ask before enrolling. Public-source editorial, without a test purchase or clinical rating.
- The best tirzepatide providers in 2026
23 historical provider records, with cost-component questions, clinical evidence limits and commercial placements explained.
- Noom Semaglutide Review: Plans, Pricing and Evidence
Compare Noom’s semaglutide plan types, advertised renewal terms, medication inclusion and evidence limits.
- How to Compare GLP-1 Costs: Fees, Refills and Renewal
Separate medication, care fees, supply duration, prepayment and renewal when comparing a GLP-1 quote.
Coreage Rx pays us a commission on sign-ups through our links. Commercial placements affect display order; the tables are not clinical recommendations. How we rate · Disclosure
